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The distinction between true myopathic disease and functional 
disorders of skeletal muscle secondary to neuronal degeneration was 
fully developed by the work of Erb (1891). The disease, known today as 
muscular dystrophy, was first reported by Meryon (1864). He remarked 
on what appeared to be a disease restricted to skeletal muscle and 
suggested the cause to be a nutritional deficiency. Eulenberg (1866 ), 
Duchenne {1868) and Sachs {1888) subsequently verified the existence of 
muscular dystrophy as a clinical entity. Muscular dystrophy is dist-
inguished as a condition of depressed functional capacity secondary to a 
primary granular and fatty degeneration of skeletal muscle fibers, whose 
etiology is unknown. The disease is conceded by all to be hereditarily 
transmitted. Bell (1943), Boyes, Fraser, Lawler and MacKensie (1949) 
and Tyler and Stephens (1950) have all reported the disease to be in-
herited as a sex-linked Mendalian dominant characteristic. 
As muscular dystrophy is transmitted genetically, it is obvious that the 
disease cannot be artificially transmitted to an experimental animal. Be-
cause of this fact, the data that has accumulated has been of human clinical 
evaluations, muscle biopsy studies and post-mortem examinations. There-
fore, with the discovery of a primary, hereditarily-induced myopathy in an 
inbred strain of mice (Ivlichelson, Russell and Harman, 1955) new interest 
in basic research of muscular dystrophy has been generated. The similar-
ities of this mouse dystrophy (called "dystrophia muscularis" by Michelson, 
Russell and Harman, 1955) and human muscular dystrophy are many 
I 
(see "Review of the Literature"). Because of these similarities, this 
animal has proved itself to be a valuable research tool in the study of 
muscular dystrophy. 
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II. REVIEW OF THE LITERATURE 
Mice exhibiting a form of muscular dystrophy were noted in an apparent 
mutation of breeding stock of inbred strain 129 mice at the Jackson 
Memorial Laboratory, Bar, Harbor, Maine. According to Michelson, 
Russell and Harman (1955), the disease is characterized by muscular 
weakness, gross atrophy of the muscles and progressive ataxia. They 
described paresis, kyphosis, convulsive nodding of the head, spasmodic 
flexion and flaccid extension of the hind limbs. There was eventual complete 
loss of locomotor function and premature death. The affected animals do 
not live a sufficient length of time to permit breeding. Stevens, Russell 
and Southard (1957) transplanted the ovaries of dystrophic mice into the 
ovarian capsules of normal female mice. The normal mouse was then 
bred and bore young. Part of this litter exhibited dystrophy. By this means, 
the latter authors were not only able to develop a stock of mice suffering from 
muscular dystrophy but were able to show that the inheritance of the disease 
followed the pattern of a single, autosomal recessive gene. Wolfe and 
Southard (1962) refined these methods, using artificial insemination to produce 
litters of all dystrophic offspring. Further work lead Russell and others 
(1962) to a new F1 strain, breeding the 129 Re-dy (dystrophic) mice and 
C57BC/6J-dy mice. These new animals have been found to possess similar 
anatomical, physiological and biochemical properties as noted in the 129 
Re-dy strain. 
After the initial report by Michelson, Russell and Harman (1955), an in-
creasing number of laboratories turned their attention to this strain of mice 
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as a valuable research tool for the study of muscular dystrophy. Sandow 
and Brust (1958) found that the dystrophic muscle of these mice was weaker 
(directly or in tension developed per gram of muscle), exhibiting less 
shortening when tension was applied. The contraction times were normal, 
but the relaxation times were increased threefold. At rest, both dystrophic 
and normal muscle possessed non-linear elasticity, but the diseased muscle 
was "stiffer". They also noted that the active state duration (that time in 
which the muscle is doing work) was shorter. Sandow and Brust (1962) also 
noted slower relaxation times and concluded that dystrophic muscle develops 
fatigue more slowly, but Solton (1962), in observing the swimming ability 
of dystrophic mice noted that these affected mice fatigued more rapidly. 
The electromygraphic studies of Mcintyre, Bennett and Brodkey (1959) 
indicated that dystrophic muscle possessed a hyperirritability to mechanical 
stimulation. The muscles exhibited spontaneous high-frequency volleys and 
fibrillation. Both the high frequency volleys and fibrillary potentials continued 
undisturbed after nerve block. Similar observations in humans by these same 
authors led them to conclude that the condition of these mice corresponded 
closely to clinical electromygraphic patterns of human dystrophia myotonica. 
Kleeman, Partridge and Glaser (1961) also noted these variations and further 
reported that the resting potentials of the dystrophic muscles were lower than 
the normals. The observation that alteration of the intra and extra~ellular 
ion concentrations had no different effect in response to electrical activity of 
dystrophic muscle as compared to normal control muscle was made by 
McLennan (1961). The electrical activity of myocardial muscles was explored 
by Kleinfeld, Magin, Murphy and Stein (1961) who found no change in intra-
cellular potential or maximum tension output in dystrophic mice as compared 
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to their littennate controls. 
West and Murphy (1960) studied the histological picture of dystrophic 
muscle of these mice and reported that the extreme variation of fiber size 
was the most conspicuous change. They noted that in cross-sections of 
the tissue the fibers round up and many become hypertrophied. There was 
a relative and absolute increase in connective tissue. This was due to the 
thickening of the endomysium and some fatty replacement. There was an 
increase in the number of nuclei and the nuclei were larger, more vesicular 
and exhibited internuclear rowing (the nuclei appeared as a string of beads). 
The sections showed coagulation necrosis, with some subsequent regeneration 
from isolated muscle nuclei and plasmodial budding. In the opinion of West 
and Murphy (1960), the existing morphological differences between mouse 
dystrophy and human dystrophy "are ones of degree rather than kind, and 
do not rule out the possibility of important similarities in mechanism and 
etiology." The "rowing" of the nuclei was also reported by Ross, Pappas 
and Harman (1960), who further noted that the myofibrils broke down by 
fragmentation and dissolution only in that region of the muscle cell where 
internuclear rowing was occurring. It was also observed that the mito-
chondria were less dense and were significantly larger with an irregular 
shape, probably due to swelling; the endoplasmic reticulum appeared 
distended or swollen in the dystrophic cells, but the sarcolemma and nuclei 
appeared to be normal. Kitigakara (1961) stated that the nuclei appeared 
consistent with those of non-proliferating tissue. His studies, utilizing 
p32 for radioautography of RNA and DNA, revealed only RNA synthesis. 
Jasmin and Bajusz (1962), noted myocardial lesions to be present late in the 
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disease, resembling those found in human muscular dystrophy, thus 
finding a similarity not noted before. 
Brat, Shull, Alfin-Slater and Ershoff (1960) studied the development 
of the long bones. They found that the dystrophic animal showed a pre-
mature closure of the epiphyseal plate. They noted osteoporosis with 
complete loss of trabeculae in the epiphysis and diaphysis at 12, 16 or 
20 weeks of age. It was their hypothesis that these changes were not due 
to disuse, but possibly due to changes in blood flow. It may be of 
significance that they could not find any evidence of change in bone in 
animals of 6 weeks of age. Leonard (1957) had earlier reported that the 
width of the tibial epiphyseal cartilages in the dystrophic mice was less 
than normal. 
The effect of denervation on the dystrophic muscle has been subjected 
to investigation. Banker and Denny-Brown (1959) found that, (1) "after 
denervation, progressive smallness of fibers in genetically determined 
dystrophy (in mice) was the most evident histological characteristic", 
(2) the turnover of c14-creatine was increased in the denervated muscle, 
(3) the greatest decrease in the creatine index (gm creatine/gm non-
collagon nitrogen) was found in denervated dystrophic muscle and, (4) 
after denervation, simple atrophy of dystrophic fibers was increased. 
Baker, Wilson, Oldendorf and Blahd (1960) suggested that the muscle of 
the dystrophic animals, like denervated normal muscle was supersensi-
tive to acetylcholine. 
The physiology and biochemistry of the dystrophic muscle has been 
studied by a number of investigators. Coleman and Ashworth (1959) found 
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that in mice two months of age, there is an increase of 603 in the content 
of desoxyribonucleic acid (DNA) and 403 in that of ribonucleic acid (RNA) 
per gram of muscle wet weight. They reported the uptake of glycine-
1-cl4 was 25-403 faster in dystrophic skeletal muscle. Because the 
dystrophic mice did not gain weight they concluded that the synthesis of 
muscle tissue was increased to compensate for the degeneration. Radio-
autographic studies by Walker (1962) have shown that dystrophic muscle 
is able to regenerate. Simon, Lessell, Gross and Milhorat (1958) worked 
with dl-leucine-1-cl4 and reported a higher incorporation rate into 
muscle over a 2-24 hour period, while the rate of disappearance of the 
isotopic carbon over a 20-30 day period from the dystrophic muscle was 
more rapid than normal. From this data, they postulated, "the loss of 
muscle protein in this mouse myppathy is not the result of a defect in 
protein synthesis, but of a more rapid turnover in which the greater rate 
of synthesis is exceeded by the increased rate of catabolism." This view 
is also held by Simon, Gross and Lessell (1962). Kruh, Dreyfus, Schapira 
and Gey (1960) studied the turnover of glycine-2-cl4 in myosin and water-
extractable proteins in normal mice (strain RAP), dystrophic mice and 
normal littermate mice (strain 129). They noted an increased uptake of 
the radioactive substance in both myosin and the water-extractable proteins 
in the dystrophic mice muscles. An increased rate of turnover was also 
observed in these same animals. According to these authors, "these results 
can be interpreted as representing a shorter life span of the muscle cell, 
or of a part of the cell or, more likely, as an acceleration of the turnover 
of the muscle proteins." Walker (1962) felt that this rapid turnover 
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reflected an accelerated taging', thus the dystrophic muscle becomes 
'oldt before the rest of the tissues. Weinstock, Epstein and Milhorst 
(1956) showed that the total niµ-ogen contents of dystrophic muscle were 
reduced and the collagen nitrogen was increased when compared to 
normal muscle on a wet weight basis, but in terms of dry weight the 
percentage of the nitrogen fractions was unchanged. Baker, Tubis and 
Blahd (1958) found that the metabolic rate, measured by collecting the 
expired air and measuring the carbon diexide production, was normal in 
dystrophic mice. However, Rosenkrantz and Laforte (1960) measured the 
oxygen consumption of tissue slices of dystrophic muscle using the 
Warburg apparatus. They reported an increase in oxygen consumption 
in a range of 40-122% in their various samples. It was reported by 
Borgman (1962) that there were no differences noted in oxygen uptake 
of tissue slices between various dystrophic animal tissues and normal 
littermate controls. The apparent discrepancies between these studies 
may be explained on the basis of different techniques. Baker, Tubis and 
Blahd (1958) also reported that the oxidation of acetate-1-cl4, measured 
as c1402 in the expired air, was at the same rate in dystrophic mice as 
in normal mice. Baker, Blahd and Hart (1958) showed that the muscles of 
dystrophic mice contained less potassium but more sodium than do the 
normal controls. The values of 12-23% less potassium and 68-107% more 
sodium, based on the fat-free dry weight of skeletal muscle, were reported 
by Young, Young and Edelman (1959). Burr and McLennan (1961) and 
Fierles (1961) however, noted that potassium has an increased exchange 
rate through the membranes of dystrophic skeletal muscle. Kandutsch 
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and Russell (1958} found a 203 decrease of muscle creatine on a wet 
weight basis. Using infra-red analysis, Young, Young, and Edelman 
(1959) observed that dystrophic skeletal muscle showed, (1) 923 in-
crease in total lipids, (2) 1683 increase in triglycerides , (3) 1403 
increase in total cholesterol, (4) 873 increase in non-esterified fatty 
acids, but (5) a normal phospholipid content. Rabinowitz (1960) noted 
that homogenized and fortified tissues of dystrophic mice have a greater 
lipogenesis and cholesterolgenesis than their littermate controls. The 
greatest differences observed by the above author were in brain tissue. 
The difference in this tissue was closely followed by the differences 
noted in liver and kidney tissues. Small differences were noted in spleen 
and skin tissues, while those in muscle tissue were insignificant. He 
stated, "that these results suggest that definite metabolic differences 
occur in the various fat-metabolizing centers of the dystrophic mice." 
Attention has been brought to bear on the enzyme activities within 
the dystrophic muscle cell. Tassoni and Harmon (1961) reported that the 
succinic dehydrogenase varied with the stage of the disease. In the 
first two to four weeks following birth, the dystrophic and control 
muscle were much the same in enzymatic activity. When five to seven 
weeks old, the dystrophic animals showed lower activity while in the 
seven to twenty week age group, the dystrophic animal showed consider-
ably higher activity than the controls. Weinstock, Epstein and Milherat 
(1958) stated that the activity of muscle succinoxidase was not affected. 
Cytochrome oxidase and cathopsinactivity were markedly increased in 
the muscles of dystrophic mice when compared to littermate controls. 
They also showed that the aldolase activity of dystrophic muscle was 
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decreased when based on wet or dry weight but was unchanged when based 
on protein nitrogen or non-collagen protein nitrogen~ Zierler (1958; 1961) 
suggested that aldolase probably diffused faster from dystrophic muscle 
than normal, which may be a reflection of increased permeability of the 
muscle. Leonard (1957) found that in the skeletal muscles of the dystro-
phic mice, the "active" and "total" phosphorylase activities were signi-
ficantly less than normal, but that the phosphorylase activity ration 
were normal. He also stated that the glycogen concentration was higher 
than normal in the dystrophic muscle. Rulon, Schottelius and Schottelius 
(1962), in further studies on phosphorylase activity, reported that its 
activity decreased with age in the dystrophic animal and that its activation 
under lengthening stimulation was variable, while that of the control 
animal showed progressive activation. They interpreted their results to 
show that there is decreased glycogenolysis in dystrophic muscle with 
advancing age of the animal. McCaman (1960) reported that some of the 
enzymes requiring triphosphopyridine nucleotide as a cofactor (glucose-
6-phosphate dehydrogenase, isocitric dehydrogenase and glutamic 
reductase) had an increased activity in dystrophic muscle, while some of 
those requiring diphosphopyridine nucleotide as a cofactor (lactie dehydro-
genase and alpha-glycerol-phosphate dehydrogenase) had a decreased 
activity. Hazzard and Leonard (1959) found that phosphoglucomutase activity 
was significantly lower in dystrophic leg muscle, determined as total 
enzyme activity (at infinite coenzyme concentration)or as residual enzyme"' 
coenzyme activity (in absence of coenzyme). The enzyme decreased with 
the age of the mouse and with the severity of myopathy. They stated that 
the "defect" seen appeared to be due to the loss of the coenzyme (glucose-I. 
6 diphosphate). Rabinowitz (1959) studied the ratio of glutamic-oxalacetic 
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to glutamic-pyruvate transaminase and found that all tissues of the 
dystrophic mouse exhibited higher activity with the sera showing the 
greatest difference. McCaman (1960) has suggested that due to the 
apparent increase in activity of the enzymes requiring TPN as a cofactor 
and the apparent decrease in activity of those enzymes requiring DPN as 
a cofactor, that abnormally high levels of reduced TPN or reduced 
glutathione may bring about an altered intra-cellular metabolism. It 
has been demonstrated (Rosenkrantz, 1959; Rosenkrantz and Laferte, 
1960) that dystrophic mice exhibit an increase in triphenyltetrazolium 
reducing activity (503 in liver, 433 in kidney and 253 in skeletal muscle). 
By introducing specific substrates, it was found that muscle showed a 
373 increase in glutamic acid dehydrogenase, but no significant change 
in activity for succinic (see above), alphaketoglutaric, isocitric, beta-
hydroxybutyric and malic dehydrogenases. Gould and Coleman (1961) 
indicated that dystrophic muscle homogenates formed acetoacetate at a 
much higher rate than normal muscle, but addition of sodium octanoate 
did not result in formation of acetoacetate in dystrophic muscle as it did 
in normal homogenates. They suggested that a heat labile factor in dys-
trophic muscle inhibited acetoacetate formation from octanoate. These 
authors reported (1962) the existence of an extractable enzyme responsible 
for acetoacetate formation in normal mice, but that it was not found in 
dystrophic tissues. Baker, Bloom and Blahd (1959) studied the formation 
of oxidation products of unsaturated fatty acids in homogenates of skeletal 
muscle, heart, kidney, brain and liver by means of a thiobarbituric acid 
assay. Their data suggested that the tissues of dystrophic mice did not 
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show a regular and significant increase in the formation of oxidation 
products of "fatty acid peroxides" over that of normal tissue. 
Zymaris, Epstein, Sailer, Arousan and Volk (1959) reported that the 
muscles of the dystrophic and control mice were qualitatively the same in 
regards to adenosine monophosphate (AMP), adenosine diphosphate (ADP}, 
adenosine triphosphate (ATP}, diphosphopyridine nucleotide (DPN), quano-
sine triphosphate (GTP}, quanosine diphosphate (GDP), uridine diphosphate 
(UDP}, enzyme creatine triphosphate (CTP) and inosine diphosphate (IDP). 
However, they did find that quantitatively the AMP, GTP and GDP were 
higher and that ATP was lower in the muscles of the dystrophic mice as 
compared to the normal control animals. In a later study, Fymaris, 
Sailer and Volk (1960) reported that by utilizing injected p32, they found 
increased levels of ADP, DPN andGDP and no difference in AMP2 ATP 
and GTP in the dystrophic muscle. In another article (1962), these same 
authors reported the above results as indicating an increased turnover 
rate of ADP, DPN and GDP. Pennington (1961) studied mitochondrial 
enzymes and found there was a 153 increase of ATP in the dystrophic 
muscle but that the succinate -INT- reductase activity was normal in these 
tissues. 
Bond and Leonard (1959} found that both normal and dystrophic mice had 
almost identical total blood, red blood cell and plasma volumes per 100 
grams of body weight. Rabinowitz (1959) reported that the blood volume 
per organ is smaller in the dystrophics. Oppenheimer, deLuca and 
Milhorat (1959) studied paper electrophoretic patterns of sera from 
dystrophic and normal littermate controls. They found no change in the 
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relative concentrations of the protein fractions, but the patterns did 
indicate a shift in distribution, particularly of lipoproteins and to a 
smaller extent of g1ycoproteins. They also stated that the concentrations 
in plasma of protein nitrogen, protein-bound lipids (free and esterified 
fatty acids) and carbohydrates (hexoses, hexosamines and sia.lic acid) did 
not vary significantly from controls. Baker, Tubis and Blahd (1958) 
indirectly gave some attention to the endocrine glands. Finding that the 
plasma levels of plasma glucose, cholesterol, protein-bound iodine131 
and liver cholesterol were normal, they concluded that the pancreas and 
thyroid must therefore be functioning properly. The data of K.andutsch 
and Russell (1958) indicated that the dystrophic mice are able to remove 
injected creatine from the blood stream more rapidly than the normals. 
Several investigators have studied food consumption and urine ex-
cretion. Baker, Tubis and Blahd (1958) found that the dystrophic mouse 
consumes more food per gram of body weight than normal, but may weigh 
as much as 333 less than their littermate controls as reported by Bond 
and Leonard (1958). Perkoff and Tyler (1958) demonstrated that the 
Strain 129 mice excreted more creatine than creatinine, but there was 
a reduction of urine creatinine in the dystrophic mice. They observed that, 
"while there was creatinuria, it was less severe than human dystrophy." 
They also noted that the dystrophic animal excreted the same creatine load 
as did the controls. McGeer, McGeer, Miller, Derry and Nichol (1962) 
reported essentially the same results. They interpreted these results to 
point out a difference between the human and the mouse forms of muscular 
dystrophy. 
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Kandutsch and Russell (1958) found that the urine creatine/creatinine 
ratios were equal and that vitamin E injection did not reduce the creatin .. 
uria of dystrophic animals to normal levels. McGaughey (1960) reported that 
Strain 129 mice excreted more alphaketoglutarate and urea than other 
species and strains of mice. He showed that the dystrophies excreted 
significantly higher levels of alpha-ketoglutarate and urea/gm of body 
weight than did controls, and that these differences increased from wean-
ing to 4 months of age. However, no significant differences were observed 
in urine excretion of amino acids, either in type or amount. It may be of 
significance that Rabinowitz (1959) determined that glucose-cl4 was oxi-
dized at the same rate in dystrophics and normal animals. 
Various attempts have been made to halt or reverse the progress of 
the disease and to prolong the life of dystrophic animals. Baker, Tubis 
and Blahd (1958) tried administration of vitamins A, D, E, B-complex and 
ascorbic acid and failed to alter the symptoms of dystrophy. These in-
vestigators (Tubis, Baker and Blahd, 1959) also reported that early therapy 
with vitamins A, D, E, thiamine, riboflavin, pyridoxine, cyanocobalamine, 
calcium pantothenate, niacinamide, folic acid, biotin, synthetic K, ascorbic 
acid, unsaturated fatty acids and choline failed to prevent paralysis and 
abnormal reflexes which are typical of the disease. The treatment had no 
effect on the skin lesions, the convulsive seizures or the early death. 
Hall, Hall and Nevis (1959) attempted parabiosis between dystrophic and 
normal mice of the same sex and strain. Their results shpwed that survival 
of dystrophics increased from a normal of 8 - 10 weeks to 24 weeks in males 
and to 25 weeks in females. The characteristic signs in these animals were 
often reduced in severity. Survival of the parabiotic pair was limited, due 
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to the development of cardiovascular disease, apparently as a con-
sequence of parabiesis. However, Pope and Murphy (1960) could not 
confirm these results. Their data indicated that a soft diet of high 
quality will increase the life span of the dystrophic mice. Miller, 
Wood and Gibson (1961) also recognized the importance of diet and 
the effect of the disease on the animal's ability to feed. They felt that 
the.se points must be considered in any drug evaluation program. The 
administration of 17-alpha-ethyl-19-nortestosterone did not restore 
the lost function of the dystrophic muscle, but did seem to retard the 
progress of the disease (Dowben, 1959). The administration of 
Testosterone proprionate and estradiol benzoate was noted by Ershoff, 
Alfin-Slater and Bernick (1961) to prevent osteoporosis of the hind 
limbs but not to alter the course of the disease. Borgman (1963) 
utilized methylandrostenediol dienanthoylacetate to prolong survival 
time but it did not affect the disease process either. 
The location of the initial lesion responsible for the disease state 
has not been specifically defined by any one study or group of studies. 
Indeed, it is painfully evident that as yet, no one biochemical locus 
even appears more promising than others. Rosenkrantz and Laferte 
(1960) are of the opinion, "that it is possible that the histopathological 
similarities of nutritional muscular dystrophy, the inherited myopathy 
of the mouse and human muscular dystrophy result from a biochemical 
lesion at a different site in the same biochemical pathway or cycle." 
Tubis, Baker and Blahd (1959) suggests, "that perhaps these animals may 
have a hereditary induced vitamin deficiency, due to the fact that vitamins 
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may not be incorporated into some necessary functional structure at 
the cellular level. Kruh, Dreyfus, Schapira and Gey (1960) stated that, 
"an acceleration of the turnover of the muscle proteins is probably the 
most important abnormality of the muscle protein metabolism in dystro-
phic mice." Walker (1962) felt that the affected tfssues undergo ac-
celerated "aging" and thus become "old" before the unaffected tissues. 
Nichol, McGeer and Miller (1962) felt that the decreased creatine 
kinase activity noted in dystrophic mouse skeletal muscle might be 
responsible for early changes that are reflected in further disease. 
Coleman (1961) linked dietary creatine and serum creatine levels to 
kidney transamidinase levels and thus indirectly to creatine kinase 
activity. 
Several authors have questioned the relationship between the human 
and mouse forms of dystrophy. Mc Geer, Mc Geer, Miller, Derry and 
Nichol (1962) stated that the differences noted in creatine and creatinine 
excretions may point to a basic difference in the diseases. In work on 
creatine phosphorylkinase content, Read (1962) found that unlike human 
muscular dystrophy, the dystrophic mouse muscle showed no difference 
between its control. Golarz and Bourne (1960) stated that human 
dystrophic muscle showed strong dephosphoralization in connective 
tissue while dystrophic mouse muscle showed this activity only spor-
adically in capillary walls. These authors felt that this finding "may 
mean the two diseases are not comparable." 
The fact that it is not possible to question any of the above statements or 
to regard one as more important than the others, is evidence of our present 
ignorance of the exact nature of muscular dystrophy. 
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III. STATEMENT OF THE PROBLEM 
From the above data, several facts appear to point to the presence 
of a biochemical lesion in the carbohydrate metabolism. Baker, Tubis 
and Blahd (1958) reported that plasma glucose was at a normal level in 
the dystrophic mice. Rabinowitz (1959) stated that glucose-cl4 was 
oxidized at the same rate in dystrophic and normal mice. The rate, as 
well as the route, of glucose metabolism is, of course, controlled by 
enzyme activity. Glucose-6-phosphate dehydrogenase was at an increased 
activity in dystrophic muscle (Mccaman, 1960), while phosphoglucomatase 
was at a decreased activity, due to the loss of its coenzyme, glucose-
1, 6 diphosphate, according to Hazzard and Leonard (1959). Earlier, 
Leonard (1957) reported that the "active" and "total" phosphorylase 
activities were significantly less than normal, but that the phosphory-
lase activity ratios of dystrophic skeletal muscle were normal. The 
activity of aldolase in dystrophic muscle was normal when based on non-
coliagen protein nitrogen (Weinstock, Epstein and Milhorat, 1958). It 
can be seen that glucose metabolism is "pointed" toward its being 
utilized for energy, rather than storage. Mccaman (1960) reported that 
alpha-glycerol-phosphate dehydrogenase was at a decreased activity, as 
was lactic dehydrogenase. This latter enzyme is of importance in anaero-
bic glycolysis, and its decreased activity would seem to indicate that 
dystrophic muscle relies mainly on aerobic glycolysis. 
A number of enzymes important in aerobic glycolysis have been 
studied. Rosenkrantz and Laferte (1960) found no significant increase 
in the activity of isocitric dehydrogenase by their technique. However, 
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using another method, Mccaman (1960) did report an increase in the acti-
vity of this enzyme. Rosenkrantz and Laferte (1960) reported that alpha-
ketoglutaric acid dehydrogenase activity was not significantly varied in 
dystrophic muscle, nor was the activity of succinic dehydrogenase altered. 
Tue activity of muscle succinoxidase was not affected, according to 
Weinstock, Epstein and Milhorat (1958). Malic dehydrogenase did not 
vary in muscles of dystrophic mice from that activity of normal muscle 
(Rosenkrantz and Laferte, 1960). Zymaris, Epstein, Saifer, Arousan and 
Volk (1959) reported on the muscle content (dystrophic and normal mice) 
of many of the coenzymes and cofactors necessary for metabolism. They 
found that dystrophic muscle had quantitatively higher amounts of adeno-
sine monophosphate, guanosine diphosphate and guanosone triphosphate 
than did normal muscle. However, the dystrophic muscles were quanti .... 
tatively lower in their content of adenosine triphosphate, the substance 
thought to provide immediate energy for work by all cells of the body. 
These above mentioned enzymes and cofactors all point to the fact that 
the tricarboxylic acid cycle is functioning properly, if not at an increased 
rate. Further evidence of this fact seems to be evident. Cytochrome oxidase 
is at an increased activity, according to Weinstock, Epstein and Milhorst 
(1958). This indicates that metabolism is accelerated, as does the re-
ported finding of Rosenkrantz and Laferte (1960) that muscle oxygen uptake 
is increased. The report that cathepsin activity in muscle is greatly in-
creased (cathepsins are those enzymes responsible for protein breakdown) 
by Weinstock, Epstein and Milhorat (1958) and that there is an increased 
muscle protein turnover (Simon, Lessell, Gross and Milhorat, 1958; Coleman 
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and Ashworth, 1959; Kruh, Dreyfus, Schapira and Gey, 1960) all indicate 
that carbohydrate metabolism must be increased in order to provide the 
energy necessary for the increased rate of muscle protein synthesis. 
It becomes obvious that if there is an increased carbohydrate 
metabolism, there must be an increased source of the raw material. 
Baker, Tubis and Blahd (1958) found that the dystrophic mouse consumes 
more food per gram of body weight than does its littermate control. How-
ever, Bond and Leonard (1958) found that the dystrophic mouse may weigh 
as much as 333 less than its littermate control. Thus, it is seen, that 
dietary intake cannot supply the now increased demand for carbohydrate. 
When proteins break down, they are reverted back to their original form 
as amino acids. These amino acids, in the course of their metabolism, 
are first deaminated. Rabinowitz (1959) found that all tissues of the 
dystrophic mouse have increased transaminase activity. The function of 
a transaminase is to take the amino group from one compound and place it 
on another. If these enzymes are at an increased activity, then the 
deaminated amino acids would be at a greater concentration. These de-
aminated amino acids may be easily incorporated into the tricarboxylic 
acid cycle. Thus, with an increased diet and the availability of de-
aminated amino acids, the tricarboxylic acid cycle would have more sub-
strate available for the production of more energy. Also, because of 
the increased rate of deamination of amino acids, more urea would be 
formed from the increased amount of amino groups liberated by the deamina-
tion. An increased urea excretion by littermate control and dystrophic 
mice of Strain 129 had been reported by McGaughey (1960). This would 
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seem to indicate that there is an increase in amino acid deamination. 
However, McGaughey (1960) also reported an increase of alpha-
ketoglutaric acid in the urine of these same animals. His findings 
indicated that the dystrophic mouse excreted a significantly higher 
amount than did the littermate controls, and that this difference in-
creased from weaning to 4 months of age (normal time of death). If the 
tricarboxylic acid cycle is operating properly, this substrate should 
not be found in the urine. It could come from several sources. If 
alpha-ketoglutarate dehydrogenase were at a decreased activity, the 
increased glucose metabolism would "flood" the enzyme and the excess 
would spill out into the urine. However, Rosenkrantz and Laferte (1960) 
reported it to be at normal activity. The kidneys could play a part 
also in the excretion of alpha-ketoglutaric acid. It is known that 
deamination of glutamic acid yields alpha-ketoglutaric acid. Glutamic 
reductase is at an increased activity (McCaman, 1960) as is glutamic 
acid dehydrogenase (Rosenkrantz and Laferte, 1960). These enzymes then 
could be responsible for the alpha-ketoglutaric acid excess found in the 
urine of Strain 129 mice (McGaughey, 1960). 
It became the object of this study to determine if alphaketoglutarate 
dehydrogenase is responsible for this excretion of its substrate. 
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IV. EXPERIMENTAL METHODS 
The mice studied were dystrophic (dydy) and heterozygous "carriers" 
(Dydy from Strain 129/Re+dy. The notation 129/Re+dy designates the 
subline of the 129 inbred strain in which the dystrophic (dydy) muta-
tion rose. The mice were obtained from the Russell B. Jackson Memorial 
Laboratories, Bar Harbor, Maine, and were approximately 2 months when 
received. They were kept in 12" x 12" wire screen cages in well venti-
lated, air conditioned animal quarters. They were fed Purina laboratory 
chow and allowed water ad libitum. 
The animals were given an intra-peritoneal injection of sodium 
pentobarbital (40 mg/kg). The gastrocnemius muscles were quickly ex-
cised and placed in a covered weighing bottle set in cracked ice. 
Motor end plates were stained using the vital methylene blue tech-
nique of C~~rs and Woolf (1959). The injection of the dye into the un-
fixed muscle and the subsequent exygenation formed a stable dye-lipid 
complex which selectively deposited the blue dye on the bare nerve end-
ings. Although the exact mechanism of this selectivity is unknown, the 
procedure constitutes an excellent means of studying gross morphology of 
nerve terminal arborization. 
The co'~rs and Woolf (1959) histochemical technique for staining 
cholinesterase was utilized for the study of post-synaptic membranes. 
This technique was originally outlined by Koelle and Friedenwald (1949) 
and modified by Couteaux (1951). In this method, cholinesterase, con -
centrated in the lamellae of the post-synaptic membrane, is complexed by 
a disulfide bond. This complex appears as fine black granules on the 
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prepared slide, and thus presents a picture of the post-synaptic membrane. 
Cholinesterase activity was determined by the method of Augustinsson 
(1948). This method measures the carbon dioxide evolved from liberated 
acetic acid when acetylcholine as a substrate is hydrolyzed by cholin-
esterase. 
The determination of the non-collagen protein nitrogen was made 
using the technique of Lilenthal, Zierler, Folk, Buka and Riley (1950). 
The method of Lanni, Dillon and Beard (1950) was used for wet combustion 
followed by direct nesslerization using the Nessler's reagent of Koch 
and McMeekin (1924). These methods provided a suitable and accurate 
reference basis for the comparison of muscles in which one group (dystro-
phic) differed significantly from the other (littermate control) in fat, 
collagon and protein content. 
Alpha-ketogluterate dehydrogenase activity was determined by the 
procedure of Kaufman, Gil vary, Cori and Ochoa (1953). The Warburg appar-
atus was set to oscillate at 90 cycles per minute, with a shaking ampli-
tude of approximately 7 cm. The water bath was maintained at 25° C. 
This method determined the activity of the enzyme by measuring the re-
lease of carbon dioxide from alpha-ketoglutaric acid, according to the 
metabolic scheme as summarized by Cantarow and Schepartz (1957). The 
results are expressed as microliters of carbon dioxide released per mg 
of fat-free, non-colliagon protein nitrogen in the tissue sample. 
Creatine phosphokinase was isolated by the first two steps of pro-
cedure B of Kuby, Noda and Lardy (1954). The enzyme activity was measured 
using the technique of Read and Nehorayan (1959). Phosphate was deter-
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mined by the method of Fiske and Subbarow (1925). This method followed 
the enzyme activity by measuring the amount of phosphorus enzymatically 
transferred from ATP to creatine. 
Alpha-ketoglutaric acid was measured in the muscle by the following 
procedure, modified from McGaughey (1960). The gastrocnemius muscles 
were removed and homogenized in 5 times their weight in distilled water. 
T\vo ml of 0.1% 2. 4-dinitrophenylhydrazine (DNPH) in 2N HCl were added to 
the homogenate and allowed to stand for 15 minutes. The homogenate-DNPH 
mixture was then extracted with 2 ml of ethyl acetate. T\vo ml of IN 
Na2co3 was added to the ethyl acetate extract, the solution acidified 
with 2N HCI and the Na2C03 extracted with 5 ml of ethyl acetate. The 
optical density of the ethyl acetate was measured at 480 mu in a spectro-
photometer (Bausch and Lomb, Spectronic 505). A reagent blank was run 
on I ml of redistilled water simultaneously with the sample. Standards 
of I, 3 and 5 mg of alpha-ketoglutaric acid in 1 ml of redistilled water 
were extracted in the same manner and similarly analyzed. The method 
eliminates most of the contaminants and excess DNPH and converts alpha-
ketoglutaric acid to the yellow hydrazone salt. 
The metabolism of pyruvate was studied in order to determine the 
efficacy of the tricarboxylic acid cycle. Radioactive labeled pyruvate 
was utilized. Injections of 0. 5 ml of saline containing 10 microcuries 
of activity of pyruvate-2-cl4 were made into the intraperitoneal cavity 
of dystrophic and littermate control mice. The mice were isolated and 
separated in all-glass metabolism cages (Roth, Leifer, Hogness and Lang-
ham, 1948) in which urine, food and feces were individually separated. 
The exhaled carbon dioxide was collected in KOH and BaC12 • One half of 
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the 24 hour urine volume was extracted for alpha"ketoglutaric acid as 
stated above, with the exception that the last ethyl acetate fraction 
was 2 ml. The other half of the 24 hour urine volume was dried on a 
planchet. The extracted urine, in the form of the ethyl acetate frac" 
tion, was also dried on another planchet. The collected cl402 now in 
the form of Bacl403 was plated on another planchet (150 mg Bacl403). 
The planchets were counted in a Geiger tube, model D47. 
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V. EXPERIMENTAL RESULTS 
Motor End Plates 
The terminal end plates and subterrninal fibers of dystrophic and non-
dystrophic littennate control mice are compared in figures 1 and 2. The 
terminal end plates are stained with methylene blue. This method employs 
methylene blue as a non-specific stain for the lipoida.l substance of nerve 
terminals and gives infonnation on only the gross morphology of the end 
plates and branching of the subtenninal fibers. 
In figure l is shown a single motor end plate of non -dystrophic control 
stained with methylene blue. In longitudinal sections of whole muscles 
(as in figure 1) the motor end plates are concentrated in narrow zones 
(innervation terminal band) situated at the mid-point of the muscle 
" (Coers, 1953). Figure 1 represents such a motor end plate. It has been 
selected because it represents a typical end plate found in mice skeletal 
muscle. It can be seen that the subterminal nerve fibers (black wavy lines 
Figure 1. Motor-End Plate From A Littermate Control Gastrocnemius 
Muscle. Methylene Blue Technique. 1150X 
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in upper right of figure 1) become increasingly separated from one 
another as they proceed distally. Titey weave in front of or behind the 
muscle fibers, crossing them approximately perpendicular. TI1e rerm-
inal fibers rllll only a short course, ending in a terminal arborization 
on the surface of a muscle fiber. TI1e terminal arborization, in methy-
lene blue preparations, show some branching with swellings on the branches. 
The branches end, not in a tapered point, but in a terminal enlargement. 
Functionally, these endings make contact with the post-synaptic membrane, 
a specialized portion of the muscle membrane. 
In figure 2 is shown a single motor end plate on a muscle fiber ta.ken 
from a dystrophic mouse. While it is somewhat smaller and exhibits 
less branching than does the motor end plate f:rom the normal mouse, it 
is still within normal limits. The terminal arborization shows branching~ 
Figure 2. Motor .. End Plate From A Dystrophic Gastrocnemius Muscle. 
Methylene Blue Technique. l 150X 
with swellings on these branches. Adams, Denny-Brown and Pearson 
(1953) described motor end plates in human dystrophic muscle. They 
found that these structures were smaller and some showed "clubbing" 
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of the entire unit. Figure 2 ha.s no such "clubbing" but it is smaller 
and appears less developed than the normal unit. These differences that 
are noted are not of a significant nature. They represent functional 
changes due to the disease present in the muscle cell. Adams, Denny-
Brown and Pearson (1953) ascribed the differences noted in human muscles 
to the fact that the muscle fiber which the unit innervates has undergone 
degeneration, and perhaps complete dissolution. The nerves to these 
fibers undergo atrophy more slowly, and thus they are seen to be smaller 
and less developed. 
Post-Synaptic Membranes 
The post-synaptic membrane taken from the skeletal muscle of a 
littcrmate control mouse is shown in figure 3. It is typical of the ap-
pearance of these structures as found in these mice and stained with 
this procedure(Augustinsson, 1946). The black precipitate is located 
within the lamellae of the membrane and thus presents a picture of the 
Figure 3. Post-Synaptic Membrane From A Littermate Control Gastrocnemius 
Muscle. Cholinesterase Stain. Koelle & Friedenwald (1949) 
Technique. llSOX 
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structure. This specialized area in the muscle membrane is functionally 
able to receive nerve impulses from the nerve terminals which make 
ftUlctional contact with this membrane. The post-synaptic membrane 
follows the pattern of the motor end plate, as shown in figure 3 . 
Tue post .. synaptic membrane of the dystrophic mouse skeletal muscle 
is seen in figure 4 . TI1e thickness of the sections necessary for this stain-
ing procedure make it difficult to obtain photographs. The membrane may 
be situated at a slight angle to the objective of the microscope. Thus, 
the examiner must focus in several points along the membrane in order 
to study the structure in its entirety. However, the camera cannot 
Figure 4 . Post-Synaptic Membrane From A Dystrophic Gastrocnemius Muscle . 
Cholinesterase Stains. Koelle & Friedenwal<l (1949) Technique. 
ll50X 
change focus in this mam1er and the resulting photograph is a composite view 
of the object being viewed. TI1is is seen in figure 4. T11is figure was included 
because it showed typical morphology when seen under the microscope. Micro-
scopically, the post- synaptic membranes conformed closely to the morphology 
of their respective motor end plates and there appeared to be no significant 
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gross difference between dystrophic muscle and littermate controls. 
Quanta tive Cholinesterase Determination 
The histochemical demonstration of cholinesterase by the Koelle and 
Friedenwald technique cannot be considered as quantative. In a series of 
slides prepared for demonstration of the post-synaptic membranes by this 
method, the dystrophic animals gave a faint staining reaction when com-
pared to the bold staining reaction of the littermate controls. It was there-
fore decided to determine the cholinesterase activity in a quantative manner. 
Cholinesterase was determined by the method of Augustinsson (1948). The 
results are shown in table 1. The test is a measurement of the carbon 
dioxide evolved from liberated acetic acid when acetylcholine as a substrate. 
Table I. 
Quantative Cholinesterase Determination of Skeletal 
Muscle of Dystrophic and Littermate Control Mice 
LITTERMATE CONTROL DYSTROPHIC 























is hydrolyzed by cholinesterase. The volume of carbon dioxide (in micro-
liters) is then referred to milligrams of non-collagen nitrogen as a reference 
base. The experiment was run for 40 minutes. The results show that there 
is no significant difference between control and dystrophic animals. Thus, 
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the difference noted in the staining intensity between the two groups may 
have been due to the fact that the smaller dystrophic muscle simply did 
not contain as much cholinesterase per unit area and therefore gave a 
less intense staining reaction. 
Fat-Free, Non-Collagon Protein Nitrogen 
It is known that there is an increase in fat in the dystrophic muscles 
(West and Murphy, 1960). Therefore, the wet weight as a reference base 
would not be satisfactory for quantative work because the two muscle 
groups differ in their fat content and any comparison on this basis would 
not reflect a true quantative comparative value. The collagen content is 
also increased in dystrophic muscle (West and Murphy, 1960) and therefore 
the fat-free, dry weight base is also inadequate for the same reason as 
given above. Lilenthal, Zierler, Folk, Buka and Riley (1950) have shown 
the validity of the fat-free, non-collagen protein nitrogen as a quantative 
reference base. Therefore, the fat-free, non-collagen protein nitrogen 
was selected as a reference base for the comparison between the two muscle 
groups. Table 2 shows the variation in the fat-free, non-collagen protein 
nitrogen content of skeletal muscle of hystrophic and littermate control mice. 
The dry weight of both groups were the same, averaging 23-243 of the wet weight. 
However, the fat content of the dystrophic muscles was 93 as compared to 
43 in the littermate control muscles. These results then, seem to agree with 
the work of West and Murphy (1960), who reported histological evidence of 
fatty replacement m dystrophic muscle. Weinstock, Epstein and Milhorat 
(1958) found 18.9 mg of non-collagen nitrogen in littermate control muscle 
and 16. 3 mg in dystrophic muscle. The results expressed in table 2 are in 
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good agreement with their results. The reduction of protein nitrogen in 
Table 2. 
The Fat-Gree, Non-Collagen Protein Nitrogen Content of Dystrophic and 
Littermate Control Mice Skeletal Muscle 
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dystrophic muscle is approximately 153, which is significant. Therefore, 
because the non-collagon nitrogen is reduced in dystrophic muscle, it is 
necessary to recognize this fact when comparing dystrophic to littermate 
control muscle. Thus, the fat-free, non-collagen protein nitrogen reference 
base provides a suitable and reasonably accurate reference base for com -
paring dystrophic and littermate control muscle. 
Creatine Phosphokinase 
The results are presented in table 3. It can be seen that dystrophic 
and littermate control muscles do not vary significantly in their levels 
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of activity. Thus, the dystrophic muscle is able to store high-energy 
phosphate bonds as readily as the littermate control muscle. 
Table 3. 
Crea tine Phosphokinase Activity of Skeletal Muscle of 
Dystrophic and Littermate Control Mice 
Littermate Control Dy strophic 
J'.N P transferred from ATP to creatine/ gm fat-free, 
non-collagen prptein nitrogen/2-1/2 minutes 




Average 10.5\.-1.1* Average 










McGaughey (1960) reported that both dystrophic and lettermate control 
of Strain 129 mice excreted more alpha-ketoglutarate and urea in their 
urine than did other strains of mice. Before approaching an enzymatic 
study, it seemed desirable to check the content of skeletal muscle as a 
means of determining if simple accumulation of alpha-ketoglutarate in 
muscle could account for the increased urinary excretion. 
The alpha-ketogluterate content of the skeletal muscle of dystrophic 
and littermate control animals is shown in table 4. The results are ex-




Alpha-Ketoglutarate Content of Skeletal Muscle from Dystrophic, 
Littermate Control Mice and Normal White Mice 
Litterma te Control Dy strophic Normal White 








The alpha-ketoglutarate in the littermate control averaged 130 mg/gm 
fat-free, non-collagen nitrogen while a normal white mouse gave a 
figure of 160, which is well within the range of the littermate control. 
The dystrophic muscle had no alpha-ketoglutarate, at least it was· below 
the minimum detectable by the test procedure. As the purpose of the 
test was to determine if a significant increase in muscle alpha-ketogluarate 
could account for the increased urinary excretion, it was felt that a 
limited number of animals would answer this question. The inability to 
detect alpha-ketoglutarate in dystrophic muscle would indicate against 
the concept that the alpha-ketoglutarate found in the urine is a result of 
this compound accumulating within the substance of dystrophic muscles. 
Alpha-Ketoglutarate Dehydrogenase 
In a further search for the biochemical lesion responsible for the 
increased urinary excretion of alpha-ketoglutarate, the alpha-ketoglutarate 
dehydrogenase activity was measured. This enzyme is responsible for 
the first step in the metabolism of alpha-ketoglutarate. A reduction 
in the enzyme level would result in a lowered ability to metabolize 
alpha-ketoglutarate and result in its excretion. 
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The alpha-ketoglutarate dehydrogenase activity of skeletal muscle 
from dystrophic, littermate controls and normal white mice is shown 
in table 5. The normal white mice are included to record a strain 
difference in the mice. The results show that the littermate control 
Table 5. 
Alpha-Ketoglutarate Dehydrogenase Activity of Skeletal Muscle from 
Dystrophic, Littermate Controls and Normal White Mice 
Littermate Control Dy strophic Normal White 













(I) 10.61** Animal 
(2) 11.~ 
(3) 9.09 
(4) 9 .09 
10.04+0.57 Average 






mice have a dehydrogenase activity of 6. 05 microliters per mg fat-free, 
non-collagen protein, while the dystrophic muscle gave a figure 653 
above this. The difference of the two means is statistically significant 
(P •. 01). These results are consistent with the low alphaketoglutarate 
content of dystrophic muscle, whereby the high level of enzymatic 
activity is sufficient to keep the alpha -ketoglutarate content low. It is 
also consistent with the adequate and normal level, when compared to 
normal white mice, of alpha-ketoglutarate content of the littermate 
control skeletal muscle. The depressed alpha-ketoglutarate dehydro-
genase activity of littermate controls, 6.05 as compared to 8.42 for 
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normal white mice, at least is consistent with the alpha-ketoglutarate 
content of these muscles. 
Pyruvate-2-cl4 Metabolism 
The results of this study are shown in table 6. To check the posibility 
of the tricarboxylic acid cycle as a possible source of the excess alpha-
ketoglutarate found in the urine, the metabolism of radio-active pyruvate 
was studied. It was felt that there was sufficient evidence that the 
tricarboxylic acid cycle was functioning and therefore, even a very 
limited study would be sufficient to clarify this point. Both the dystrophic 
and littermate control mice were able to metabolize pyruvate. Radio-
active labeled carbon dioxide was detected in the exhaled air of these 
animals. The urine revealed the presence of cl4, of which a part was 
in the form of alpha-ketoglutaric acid. These results may be interpreted 
Table 6. 
Pyruvate-2 .... cl4 Metabolism of Dystrophic and Littermate Control Mice 
Urine Exhaled C02*** 
Counts per Minute 
Untreated* Extracted** 
Littermate Control* 18' 191 4,060 1,522 





Both groups received 10 microcuries of cl4 labeled pyruvate 
One-half of the 24 hour urine volume 
The ethyl acetate fraction of the extracted 24 hour urine volume 
Counted as 150 mg of Bacl403 
as showing that a part of the alpha-ketoglutaric acid found in the urine of 
Strain 129 mice is originating from pyruvate metabolism. As pyruvate 
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is a product of glucose metabolism, it may be further postulated that glucose 
metabolism contributes to the alpha-ketoglutaric acid found in the urine of 
these animals. It is also possible that rapid conversion of alanine to pyru-
vate is the pathway to the excess alpha-ketoglutarate. 
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VI. DISCUSSION 
Michelson, Russell and Harman (1955) reported that there was an 
absence of apparent lesions in the nervous system of the dystrophic 
mice. They did not, however, include studies on the motor end plated 
and post-synaptic membranes. The present report is consistent with 
the view that the muscular dystrophy of mice is a disease of muscle and 
does not involve the nerve terminals. 
A consistent observation in all studies of muscular dystrophy is the 
increased excretion of urinary creatine, decreased excretion of 
creatinine and a decreased ability to retain injected creatine (Milhorat 
and Wolff, 1937). The work of Benedict, Kalinsky, Scarrone, Wertheim 
and Stetten (1955) incicated, at least in human patients, that no defect 
existed in creatine synthesis but that the excess urinary creatine was 
due to an inability of creatine to enter the muscle cell. Heinrich and 
Mattill (1949) concluded that the increased urinary excretion of creatine 
of vitamin E-deficient rabbits was due to defective phosphorylation of 
creatine. Hummel (1948) agreed with the latter viewpoint, for, in his 
experiments with tissue homogenates, skeletal muscle from vitamin 
E-deficient rabbits had a low ability to phosphorylate creatine. It had 
been reported that muscle creatine is the precursor of urinary creatinine 
(Block, Shoenheimer and Rittenberg, 1941), a reaction which proceeds 
through a preliminary phosphorylation of creatine within the muscle cell 
(Ennor, Rosenberg and Armstrong, 1955). The low activity of the enzyme, 
creatine phosphorylkinase, was interpreted to mean that the non-phosphory-
lated creatine was unable to be transferred into the muscle cell and hence 
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was excreted. However, Dinning and Fitch (1958) showed that the turn-
over rate of creatine was elevated in skeletal muscle of vitamin E-deficient 
rabbits. This implied that, rather than not being able to penetrate the 
muscle cell, the creatine molecule was able to penetrate at even a greater 
than normal rate. Read and Nehorayan (1959) showed that in early vitamin 
E-deficient rabbits, at a time when the urinary creatine excretion was 
rising, the enzyme, creatine phosphorylkinase, was higher than normal. The 
latter authors then rejected defective phosphorylation as causing the urinary 
excretion, in conformity to the results of Dinning and Fitch (1958). 
The above discussion concerning vitamin E-deficient animals is not 
intended to imply a similarity between the vitamin deficiency and muscular 
dystrophy. It is intended to call attention to hypotheses concerning the 
origin of the increased urinary creatine. 
To carry the analysis further, Feuer and Wollemann (1952) reported 
that creatine was bound to the actin molecule. They further suggested 
that creatine phosphorylkinase, bound to actin, was necessary for actin 
p0Jyme:tizatio11. Strohman (1959) recently reported that the creatine 
phosphorylkinase system is intimately concerned in actin polymerization 
by reversible phosphorylation-dephosphorylation of the actin bound 
nucleotide. Read (1960) submitted tentative evidence for the participation 
of creatine in actin polymerization which suggested that creatine was 
bound to actin and participated in actin polymerization by serving as the 
phosphate acceptor from actin bound nucleotide during polymerization. 
This reaction is enzymatically catalyzed by creatine phosphorylkinase. 
Hence, by inference, deficiency of creatine phosphorylkinase, leads to 
a deficiency of actin polymerization and an inability to contract. Indeed, 
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Read and Johnson (1959) reported data on foetal rabbits, which showed 
that, in skeletal muscle, the appearance of the enzyme, creatine 
phosphorylkinase, occurs coincident in time of foetal development with 
the appearance of contractility. Hence, in any study of the specific 
biochemical lesion of muscular dystrophy, the demonstration of de-
pressed activity of creatine phosphorylkinase is of importance and 
could explain most of the symptoms. Pertinent to the present discussion, 
is the report of Ronzoni, Wald, Berg and Ramsey (1958) who stated that 
the creatine kinase activity of skeletal muscle of human muscular dys-
trophy is only 20 to 40 percent of normal control muscle. This would 
indeed suggest at least the possibility of deficient phosphorylation as 
the cause of the inability of muscle to incorporate and retain creatine 
and explain many of the dystrophic symptoms. While some criticism 
of this work can be made on the grounds of a rather crude enxyme 
preparation, the necessity of excessively small samples from humans 
precludes extensive purification. Their data is suggestive and should 
be explored further. The data reported in the present work indicates 
that the enzyme levels of dystrophic and normal mouse muscle do not 
differ. This discrepancy between human and mouse dystrophic muscle 
is important, to resolve, for it may indicate a fundamental difference 
between human and mouse dystrophy. 
It is readily apparent that the activity of alpha-ketoglutarate dehydro-
genase is greatly increased in the skeletal muscle of dystrophic mice. 
This increase in activity may be due to an increase in the amount of 
alpha-ketoglutaric acid "delivered" to the enzyme for metabolism. 
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Protein anabolism and catabolism are increased in the dystrophic mice 
(Simon, Lessell, Gross and Milhorat, 1958; Coleman and Ashworth, 
1959; Kruh, Dreyfus, Schapira and Gey, 1960). The amino acids thus 
liberated from protein breakdown will be available for re-synthesis, or 
may be metabolized. Deamination is the first step in the metabolism of 
amino acids. It has been reported (Rubinowitz, 1959) that the ratio of 
glutamic-oxalacetic transaminase to glutamic-pyruvate transaminase is 
increased in all tissues of the dystrophic mice, with the sera showing 
the greatest difference. Chowdhury, Pearson, Fowler and Griffith (1960) 
have reported increased serum transaminase levels in human patients 
with progressive muscular dystrophy. Thus, if the transaminases are 
increased in this disease, it can be seen that the deamination of the now 
increased production of amino acids from the increased protein break-
down will result in more substrate for the tricarboxcylic acid cycle and 
an increase in amino groups. These amino groups may then be trans-
ferred to alpha-ketoglutaric acid forming glutamic acid. As glutamic acid 
acid dehydrogenase activity is increased in dystrophic muscle (Rosenkrantz, 
1959) this new load of amino groups can be passed to the ornithine-citrulline-
urea cycle without "backing up" at the glutamic acid site. If this portion 
of protein metabolism is functioning at an increased activity, it can be 
seen that the high amounts of urea found in the uririe of the dystrophic 
mice (Mc Ga ughey, 1960) is an expected finding. 
When glutamic acid passes its amino group to the urea cycle, alpha-
ketoglutaric acid is regenerated and made available for further transamination 
of amino acids, and the eventual production of urea. An increase in oxygen 
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consumption in dystrophic muscle has been reported by Rosenkrantz 
and Laferte (1960); cytochrome oxidase is reportedly increased, also 
(Weinstock, Epstein and Milhorat, 1958). These increases may be 
interpreted as indicating an overall increase in the activity of the tri-
carboxcylic acid cycle. Thus, additional alpha-ketoglutaric acid may be 
formed to help in the deamination of amino acids. However, McGaughey 
(1960) reported an increase in alpha-ketoglutaric acid in the urine of 
Strain 129 mice, with the dystrophic mice having a significantly higher ex-
cretion than the normals. This study has ffiown that alpha-ketoglutarate 
dehydrogenase is at an increased activity in the dystrophic leg muscles. This 
finding, then, does not explain the data of McGaughey (1960). The prelimin-
ary study in this paper seems to indicate that pyruvate metabolism through 
the tricarboxcylic acid cycle to alpha-ketoglutaric acid is functioning, and 
that a portion of the alpha-ketoglutaric acid found in the urine of the dystro-
phic mice may come by way of this route. In view of these findings, it 
appears as if an excess of alpha-ketoglutaric acid is formed through the 
increased protein breakdown, resulting in increased amino acids (in 
particular, glutamic acid which may be deaminated by glutamic acid 
dehydrogenase and thereby directly form alpha-ketoglutaric acid) and an 
increased activity of the tricarboxcylic acid cycle. This excess production, 
resulting in the presence of alpha-ketoglutaric acid in the urine of Strain 
129 mice, may then exceed the metabolism of alpha-ketoglutaric acid 
by the tricarboxcylic acid cycle, or it may be a function of the kidneys, or 
a combination of these two factors. 
The littermate control mice present s:>mewhat of a different problem. 
This strain of mice presents two distinct genetic groups, represented as 
129/Re-ldy subline and 129/J subline (communication from Russell B. Jackson 
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Memorial Laboratory, Bar Harbor, Maine). The 129/J subline is referred 
to as DyDy (homozygous normal controls) in which dystrophy has not been 
reported. The subline 129 /Re dy has the given genetic description of 
Dydy (heterozygote, or littermate control), Dy? (control) and dydy 
(dystrophic). The animals used as controls in this stutly were of the Dydy 
and Dy? groups. It is apparent that these animals may have a predis-
position toward dystrophy and that their label of "normal" is based on the 
absence of clinical signs of the disease. Thus, though they differ from 
normal white mice and the dystrophic mice activity levels, an attempt to say 
that the difference is of etiological importance is rather presumptuous. 
However, this fact cannot be completely disregarded. The explanation, of the 
lowered activity in these animals, must await more refined techniques in 
the correlation of disease with heredity. 
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VII. SUMMARY 
1. Gastrocnemius muscles of dystrophic mice present essentially 
the same pattern as normals in regard to motor end plates and post-
synaptic membranes. 
2. Alpha-ketoglutarate dehydrogenase activity is increased in 
dystrophic leg muscle as compared to littermate controls. Normal 
white mice leg muscles have an activity that is intermediate between 
littermate control and dystrophic leg muscles. This increase in dystro-
phic muscle may be expected, due to an increase in activity of the 
tricarboxcylic acid cycle and an increase in protein breakdown. 
3. Crea tine phosphokinase activity does not vary significantly 
between dystrophic leg muscle and littermate control leg muscle. 
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